Genetic testing by cancer site: uterus

Area of Science:

• Gynecology
• Oncology
• Genetics

Background:

• Hereditary cancer predisposition syndromes are genetic conditions increasing cancer risk.
• Uterine manifestations, including endometrial and smooth muscle tumors, occur in several syndromes.
• Early identification and management are crucial for improving outcomes.

Purpose of the Study:

• To review hereditary cancer predisposition syndromes with uterine manifestations.
• To discuss Lynch syndrome, PTEN hamartoma tumor syndrome, and HLRCC in relation to uterine cancers and tumors.
• To outline screening and prevention strategies for at-risk individuals.

Main Methods:

• Literature review of hereditary cancer syndromes affecting the uterus.
• Focus on Lynch syndrome, PTEN hamartoma tumor syndrome (Cowden syndrome), and HLRCC.
• Synthesis of information on clinical characteristics, genetic basis, and management.

Main Results:

• Lynch syndrome is associated with 2-3% of endometrial cancers.
• PTEN hamartoma tumor syndrome increases endometrial cancer risk.
• HLRCC carries a high risk of symptomatic uterine leiomyomas.

Conclusions:

• Recognizing uterine manifestations of hereditary cancer syndromes is vital for timely diagnosis.
• Genetic counseling and tailored screening protocols are essential for women at risk.
• Proactive management can mitigate the risk of gynecologic malignancies and associated complications.